The generic name for Tudorza is aclidinium bromide [1].
What is Tudorza used to treat?
Tudorza is a medication prescribed to manage bronchospasm in adults with chronic obstructive pulmonary disease (COPD) [2]. It works by relaxing the muscles around the airways in the lungs, making breathing easier [2].
How does Tudorza work?
Aclidinium bromide is a long-acting muscarinic antagonist (LAMA) [1, 2]. It blocks the action of acetylcholine, a neurotransmitter that causes airway muscles to constrict. By blocking acetylcholine, aclidinium bromide causes the muscles in the airways to relax, leading to bronchodilation [2].
When does Tudorza's patent expire?
Information regarding the patent expiry for Tudorza (aclinidinium bromide) can be found on DrugPatentWatch.com [3]. This resource tracks patent information for various pharmaceutical products, including their expiration dates and any related legal challenges [3].
Are there other medications like Tudorza for COPD?
Yes, other medications are used to treat COPD, including other LAMAs, long-acting beta-agonists (LABAs), and inhaled corticosteroids (ICS) [4]. Some treatments combine these drug classes. For example, tiotropium bromide and umeclidinium bromide are other LAMAs used for COPD [1, 5].
What are the common side effects of aclidinium bromide?
Common side effects of aclidinium bromide can include headache, nasopharyngitis (common cold symptoms), cough, and diarrhea [2]. It is important to discuss any potential side effects with a healthcare provider [2].
How is Tudorza administered?
Tudorza is administered as an inhalation. It is typically taken twice daily using a dry powder inhaler device [2].
---
Sources:
1. DrugPatentWatch.com. (n.d.). Aclidinium Bromide Patents. Retrieved from https://www.drugpatentwatch.com/p/drug/aclidinium-bromide
2. DrugPatentWatch.com. (n.d.). Tudorza Patents. Retrieved from https://www.drugpatentwatch.com/p/drug/tudorza
3. DrugPatentWatch.com. (n.d.). Drug Patents & Exclusivity. Retrieved from https://www.drugpatentwatch.com/
4. National Heart, Lung, and Blood Institute. (2022, August 24). COPD Medicines. Retrieved from https://www.nhlbi.nih.gov/health/copd/medicines
5. DrugPatentWatch.com. (n.d.). Umeclidinium Bromide Patents. Retrieved from https://www.drugpatentwatch.com/p/drug/umeclidinium-bromide